Transcept, Novo seek FDA approvals; Alcon plans big growth in Fort Worth;

@FierceBiotech: Intercell seeks drug-patch partners after stock meltdown. Report | Follow @FierceBiotech

@RyanMFierce: @JohnCFierce it's like the top 10 pharma wants to date RNAi without telling anyone. Did someone say RNAi has cooties? | Follow @RyanMFierce

@MaureenFierce: Childhood vaccine funds agreed for more poor nations. Article | Follow @MaureenFierce

> Transcept has re-submitted its NDA for the sleep drug Intermezzo. Report

> Joining the line forming in front of the FDA, Novo Nordisk has filed its insulin hopeful degludec for an approval. Novo also filed for marketing approval in Europe. Story

> Alcon is asking the city of Fort Worth, TX, for some tax breaks on a planned expansion that's expected to create 750 jobs over the next 7 years. The growth in Fort Worth will consolidate the new Novartis unit's finance services operations in one place, the Fort Worth Star-Telegram reports. Article

> Jeffrey Tobias has jumped from his post at NeurogesX to the CMO position at Jazz Pharmaceuticals. Release

> Tarix Pharmaceuticals has won orphan drug status for its experimental drug for pulmonary arterial hypertension. Story

Pharma News

@FiercePharma: Merck joins drug cos. looking outside pharma for expertise: New strategy chief from Lenovo Article | Follow @FiercePharma

> GSK chief backs affordable pricing in India. Report

> JAMA: Spotty results with off-label antipsychotic use. News

> Indian panel rejects cap on pharma M&A, backs commission review. Report

> Gardasil wins an HPV cost-effectiveness match-up. Item

Drug Delivery News

> 'Nano-swimmers' could carry drugs to tumors. News

> FDA clears Smiths Medical's wireless infusion pump. Story

> Pacira's long-acting pain drug advancing. Story

> U.K.'s Silence grabs RNAi delivery deal with Big Pharma. Report

> Intercell seeks drug-patch partners after stock meltdown. Item

> Roche trial buoys antibody-based delivery of cancer drugs. Piece

Medical Device News

@FierceMedDev: Shuren says guidance on de novo coming shortly. #AdvaMed2011 | Follow @FierceMedDev

> J&J unit to buy SterilMed. Article

> DJO, Exos ink distribution agreement. Item

> Sony buys Micronics to enter new field. Report

> SpineGuard scores $6.2M. More

And Finally... New research at Michigan State helps expand our understanding of how people continue to learn while they sleep. Article

Suggested Articles

German researchers uncovered 28 antibodies that neutralize COVID-19 and are working with Boehringer Ingelheim to advance them into clinical testing.

Oragenics is ending a phase 2 study of its oral mucositis drug, yanking its IND application and switching its focus to a COVID-19 vaccine.

The vehicle, which Blackstone claims is the largest life sciences private fund, has committed close to $1 billion to companies including Alnylam.